CBIS News Archive

Display # 
Cannabis Science (CBIS) Moves Forward with Critical Support of Landmark Federal Cannabis Legislative Initiative 02 Dec 2013
Cannabis Science Working with Cannabis Caucus in the U.S. House of Representatives in the Fight to Level the Playing Field for Cannabis Drug Research and Development 25 Nov 2013
Cannabis Science, Inc. (CBIS) Announces Broad Patent Licensing Agreement with Endocan Corporation (ENDO) to Develop the Cannabinoid-Based Patent N2010968 'Composition for the Treatment of Neurobehavioral Disorders' for Over-the-Counter, Dispensary, and Fo 21 Nov 2013
Cannabis Science, Inc. (CBIS) Promotes Robert Kane to Chief Financial Officer (CFO), Board of Directors 20 Nov 2013
Cannabis Science, Inc. (CBIS) Featured in A&U Magazine Regarding Potential Utility of Cannabinoids to Address Emerging Crisis of HIV Drug Resistance 18 Nov 2013
Cannabis Science, Inc. (CBIS) Announces Submission of Cannabinoid-Based Patent Application N2010968 Titled 'Composition for the Treatment of Neurobehavioral Disorders' 15 Nov 2013
Cannabis Science Announces The Depository Trust Company (DTC) Lifts Share Trading "Chill" Effective Immediately 06 Sep 2013
Cannabis Science Appoints Clinical Development Expert, Dr. Dorothy Bray, as Chief Executive Officer (CEO) and Director, Focusing on CS-TATI-1 and Building Company's Drug Development Pipeline 29 May 2013
Cannabis Science Announces Preclinical Development Program for CS-TATI-I, Commencing EU Operations in the Netherlands and Sourcing Proprietary Material for Pharmacokinetic Characterization 26 Apr 2013
Cannabis Science Announces Screening of 'American Drug War II,' Film by Kevin Booth, on Thursday, April 18 16 Apr 2013